| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.5 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.6 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.033 | 0.6 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |